Clinical trials · North Carolina
Thrombosis clinical trials in North Carolina
We’re tracking 9 recruiting thrombosis studies with a site in North Carolina — including Phase 2 and Phase 4 studies, each written for real people, not researchers.
Recruiting studies in North Carolina
- NCT04398628Recruiting
Study of non-cancer blood disorders in people with bleeding or clotting
This study follows people with inherited or acquired non-cancer blood disorders to better understand symptoms, causes, and how different treatments work over time. You may be placed into a disorder-specific group, depending on your diagnosis and testing results.
Chapel Hill, North CarolinaAges Any age - NCT06394739Recruiting
RevCore for blood clots in leg stents
This trial tests a special catheter to remove blood clots that have formed inside a leg vein stent. It may be an option for people who have had a stent in place for more than 6 weeks and have a new clot in certain leg veins.
Asheville, North CarolinaAges 18 years+ - NCT05701917Recruiting
Clot-busting device versus blood thinners for leg clot
This study compares a clot-removal device (ClotTriever) plus standard care versus standard blood thinners alone for a deep vein clot in the leg. It aims to see which approach better improves leg symptoms and outcomes.
Asheville, North CarolinaAges 18 years+ - NCT04862468RecruitingPhase 2
Dexamethasone after clot removal to calm leg swelling
This Phase 2 study tests whether a steroid medicine called dexamethasone can reduce inflammation after a clot (DVT) is removed in the thigh/behind-knee veins. If it works, it may help improve recovery and reduce ongoing leg problems after the procedure.
Raleigh, North CarolinaAges 18–89 - NCT06820515Recruiting
Blood disorder patient registry for all ages
This study is a registry (a large database) that collects information from people who have or may have a blood disorder. It helps researchers learn more about these conditions and improve care.
Hickory, North CarolinaAges Any age - NCT03797495Recruiting
Study for people with low plasminogen or their close family
This study looks at people diagnosed with type 1 plasminogen deficiency (a condition with low plasminogen levels) and can also include their first-degree family members. It may help researchers learn more about the condition and how to monitor it over time by collecting blood and genetic information.
Raleigh, North CarolinaAges Any age - NCT06523166Recruiting
Comparing heart CT and ultrasound for Watchman device checking
This study compares two types of heart imaging (a CT scan and an ultrasound) to see how well they work at checking the Watchman device after it is placed. The goal is to see if the CT scan might be a good alternative to the standard ultrasound for follow-up.
Charlotte, North CarolinaAges 18 years+ - NCT04647227RecruitingPhase 4
SEVENFACT® to reduce bleeding in hemophilia with inhibitors
This trial studies whether SEVENFACT® can reduce bleeding episodes in people with hemophilia A or B who have inhibitors (proteins that make standard treatments less effective). It also tests how well people can track bleeding and medicine use during the study.
Greenville, North CarolinaAges 12–100 - NCT06676904Recruiting
Platelet transfusion study for very preterm babies
This study looks at the best way to decide when to give platelet transfusions to very premature babies. It aims to help prevent bleeding while avoiding unnecessary transfusions.
Durham, North CarolinaAges 1 hour–2 days
Where these studies are running in North Carolina
Institutions with a site for the recruiting thrombosis studies listed above.
- East Carolina University · 2 studies
- Mission Hospital · 2 studies
- Wake Forest University Health Sciences · 2 studies
- American Thrombosis and Hemostasis Network
- Duke University
- NC Heart and Vascular Research
- Sanger Heart and Vascular Institute
- St. Jude Affiliate Clinic at Novant Health Hemby Children's Hospital
What taking part in a thrombosis study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Thrombosis trials in other states
Common questions
- Are there thrombosis clinical trials in North Carolina?
- Yes. We're currently tracking 9 recruiting thrombosis studies with a site in North Carolina, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a thrombosis study in North Carolina?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in North Carolina to take part?
- Not necessarily. These studies have a site in North Carolina, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a thrombosis trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New thrombosis studies open in North Carolina regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.